Objective-The goal of this study was to investigate the mechanisms by which apolipoprotein (apo) A-I, in the lipid-free form or as a constituent of discoidal reconstituted high-density lipoproteins ([A-I]rHDL), inhibits high-glucose-induced redox signaling in human monocyte-derived macrophages (HMDM). Methods and Results-HMDM were incubated under normal (5.8 mmol/L) or high-glucose (25 mmol/L) conditions with native high-density lipoproteins (HDL) lipid-free apoA-I from normal subjects and from subjects with type 2 diabetes (T2D) or (A-I)rHDL. Superoxide (O 2 Ϫ ) production was measured using dihydroethidium fluorescence. NADPH oxidase activity was assessed using lucigenin-derived chemiluminescence and a cyotochrome c assay. p47phox translocation to the plasma membrane, Nox2, superoxide dismutase 1 (SOD1), and SOD2 mRNA and protein levels were determined by real-time polymerase chain reaction and Western blotting. Native HDL induced a time-dependent inhibition of O 2 Ϫ generation in HMDM incubated with 25 mmol/L glucose. Lipid-free apoA-I and (A-I)rHDL increased SOD1 and SOD2 levels and attenuated 25 mmol/L glucose-mediated increases in cellular O 2 Ϫ , NADPH oxidase activity, p47 translocation, and Nox2 expression. Lipid-free apoA-I mediated its effects on Nox2, SOD1, and SOD2 via ABCA1. (A-I)rHDL-mediated effects were via ABCG1 and scavenger receptor BI. Lipid-free apoA-I from subjects with T2D inhibited reactive oxygen species generation less efficiently than normal apoA-I. 
O xidative stress and reactive oxygen species (ROS) production play a crucial role in the pathogenesis of diabetes and its complications. [1] [2] [3] [4] The mechanisms of ROS production in subjects with diabetes include activation of the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, glucose autoxidation, and advanced glycation end-product production. [5] [6] [7] Superoxide radicals (O 2 Ϫ ) generated by NADPH oxidase and the mitochondrial respiratory chain may contribute to the accelerated atherosclerosis observed in patients with diabetes. 8, 9 Recent studies have suggested that the Nox (NADPH oxidase) subunits of NADPH oxidase are prominent sources of vascular ROS and have been linked to diabetes. 10, 11 An inverse relationship between the concentration of highdensity lipoprotein (HDL) cholesterol and the development of coronary heart disease has been established in many largescale population studies. 12, 13 HDL and their major protein component, apolipoprotein A-I (apoA-I), have a number of antiatherogenic properties. These include promotion of cholesterol efflux from macrophages in the artery wall and their participation in reverse cholesterol transport. 14 More recently, it has been demonstrated that both HDL and apoA-I possess antioxidant and antiinflammatory properties. [15] [16] [17] The antioxidant properties of HDL have been documented in vitro and in vivo 18 -20 and attributed both to apoA-I and to HDL-associated proteins, such as paraoxonase. This enables HDL to inhibit low-density lipoprotein oxidation 19 and protect resting neutrophils from respiratory burst activation. 18, 21 A number of studies provide evidence that HDL apolipoproteins in subjects with type 2 diabetes (T2D) undergo posttranslational, nonenzymatic glycation-dependent changes that impair HDL structure and function. [22] [23] [24] [25] The antioxidant properties of HDL from patients with T2D are still not fully elucidated.
In this study, we showed that both native HDL, lipid-free apoA-I and discoidal reconstituted HDL containing phosphatidylcholine complexed with apoA-I ([A-I]rHDL) inhibit ROS production, NADPH oxidase activity, p47phox translocation from the cytoplasm to the plasma membrane, and Nox2 expres-sion in human macrophages stimulated with high glucose. Furthermore, both apoA-I and (A-I)rHDL increased levels of the antioxidants superoxide dismutase 1 (SOD1) and SOD2 in human monocyte-derived macrophages (HMDM) under highglucose conditions. We also show that the antioxidant properties of apoA-I from patients with T2D are impaired.
Methods
HMDM were prepared from white cell buffy coats obtained from healthy donors and differentiated at 37°C over 9 days. HMDM were then incubated in the absence or presence of apoA-I in the lipid-free form or as a constituent of discoidal rHDL, with native HDL isolated from normolipidemic subjects or from subjects with T2D and microvascular complications. The incubations were carried out under serum-free conditions for 16 hours, and then cells were stimulated for 8 hours with 25 mmol/L glucose. Control cells were incubated with 5.8 mmol/L glucose. Intracellular ROS levels were measured using dihydroethidium (DHE) fluorescence. NADPH oxidase activity was assessed by the cytochrome c reduction assay and lucigeninderived chemiluminescence. The translocation of p47phox subunit of the NADPH oxidase from the cytoplasm to the plasma membrane was assessed as the ratio of p47phox protein expression in membrane and cytoplasm fractions using Western blot analysis. Nox2, SOD1, and SOD2 mRNA and protein levels were assessed using standard techniques. ATP-binding cassette A1 transporter (ABCA1), ATPbinding cassette transporter G1 (ABCG1), and scavenger receptor BI (SR-BI) expression was knocked down by transfection with targetspecific short interfering RNAs (siRNAs). Apocynin, an NADPH oxidase inhibitor; allopurinol, a xanthine oxidase inhibitor; and tenoyltrifluoroacetone, a mitochondrial electron chain transport complex II inhibitor were used in some experiments.
Methods are described in detail in Supplemental File I, available online at http://atvb.ahajournals.org.
Results

Effect of Lipid-Free apoA-I and Discoidal (A-I)rHDL on High-Glucose-Induced Intracellular ROS Generation in HMDM
The cell-permeable redox indicator DHE was used to assess intracellular formation of ROS in HMDM exposed to 5.8 (control) and 25 mmol/L glucose. DHE penetrates the cells and is oxidized by ROS to form ethidium, which binds to DNA to produce red nuclear fluorescence. 26 As assessed by an increase in nuclear DHE staining, incubation of HMDM with 25 mmol/L glucose for 8 or 24 hours increased intracellular ROS production ( Figure 1A ). DHE fluorescence increased by 130.5Ϯ9.1% (PϽ0.01) after 8 hours of stimulation with 25 mmol/L glucose. At 24 hours, the increase in DHE fluorescence was 85.2Ϯ15% (PϽ0.05). Incubation for 24 hours with 25 mmol/L mannitol (osmotic control) did not affect DHE fluorescence in HMDM.
Incubation of HMDM for 8 hours with concentrations of glucose ranging from 1 to 25 mmol/L showed a significant increase in DHE fluorescence only at 25 mmol/L (PϽ0.05), but no changes were observed at lower concentrations (Supplemental Figure IA) . Preincubation of the cells with 52 mol/L cyclodextrin did not affect intracellular ROS production (Supplemental Figure IB) .
To investigate whether lipid-free apoA-I and discoidal (A-I)rHDL were able to inhibit the intracellular increase in ROS induced by 25 mmol/L glucose, DHE fluorescence was assessed in HMDM that were preincubated for 16 hours with lipid-free apoA-I or discoidal (A-I)rHDL (final apoA-I concentration, 1 mg/mL) before stimulation with 25 mmol/L glucose for 8 hours ( Figure 1B ) and 24 hours ( Figure 1C ). When HMDM were preincubated with lipid-free apoA-I or discoidal (A-I)rHDL, the ROS generation by 8 hours of incubation with 25 mmol/L glucose was inhibited by 52Ϯ16% (PϽ0.05) and 57Ϯ9% (PϽ0.01), respectively ( Figure 1B ). When the incubation with 25 mmol/L glucose was increased to 24 hours, preincubation with lipid-free apoA-I and (A-I)rHDL inhibited ROS generation by 61Ϯ7% (PϽ0.01) and 41Ϯ13% (PϽ0.05), respectively ( Figure 1C ).
Effect of Native HDL, Lipid-Free apoA-I and Discoidal (A-I)rHDL on High-Glucose-Induced Extracellular ROS Generation and NADPH Oxidase Activity in HMDM
To determine whether native HDL, lipid-free apoA-I and (A-I)rHDL also inhibit high-glucose-induced extracellular ROS generation, we used a cytochrome c reduction assay. Because of the inability of cytochrome c to penetrate cells, this technique was used to measure extracellular ROS generation. 27 As shown in Figure 2A ( Figure 2B ). Furthermore, preincubation of HMDM with lipidfree apoA-I or (A-I)rHDL (final apoA-I concentration, 1 mg/ mL) for 16 hours reduced 25 mmol/L glucose-induced extracellular ROS production by 71Ϯ3% and 47Ϯ5%, respectively (PϽ0.01 for both) ( Figure 2C ). To provide direct evidence for the effect of lipid-free apoA-I and (A-I)rHDL on high-glucose-induced NADPH oxidase activity, we then used a lucigenin-derived chemiluminescence assay to measure NADPH oxidase activity. As shown in Figure  2D , incubation of HMDM for 8 hours with 1 to 25 mmol/L glucose increased NADPH oxidase activity by 55Ϯ13% only at 25 mmol/L glucose (PϽ0.05). When the cells were preincubated with lipid-free apoA-I or (A-I)rHDL (final apoA-I concentration, 1 mg/mL) for 16 hours, the NADPH oxidase activity decreased by 41Ϯ7% and 43Ϯ12%, respectively (PϽ0.05). Preincubation of the cells with 52 mol/L cyclodextrin, by contrast, did not affect NADPH oxidase activity ( Figure 2E ).
Effect of Lipid-Free apoA-I and Discoidal (A-I)rHDL on High-Glucose-Induced p47phox Translocation From the Cytoplasm to the Plasma Membrane
The activation of the NADPH oxidase is regulated by the translocation of p47phox from the cytoplasm to the plasma membrane. It has been shown that p47phox translocation promotes the activity of the NADPH oxidase in monocytes and macrophages. 28, 29 p47phox expression was therefore assessed in membrane and cytosolic protein fractions from HMDM incubated with 25 mmol/L glucose in the presence or absence of lipid-free apoA-I and (A-I)rHDL. As expected, 25 mmol/L glucose increased p47phox translocation by 36Ϯ8% (PϽ0.05) (Supplemental Figure II) . Both lipid-free apoA-I and (A-I)rHDL significantly inhibited the glucosemediated increase in p47phox translocation by 64Ϯ5% and 67Ϯ14%, respectively (PϽ0.01). The ability of lipid-free apoA-I and (A-I)rHDL to inhibit ROS generation was lost in cells preincubated with apocynin, an NADPH oxidase inhibitor (Supplemental Figure IIIA) . On the other hand, the inhibitory effect of lipid-free apoA-I and (A-I)rHDL on ROS generation was preserved in macrophages preincubated with inhibitors of the xanthine oxidase, 
The Effect of
Effect of Lipid-Free apoA-I and Discoidal (A-I)rHDL on Nox2, SOD1, and SOD2 mRNA Levels and Protein Expression
The ability of lipid-free apoA-I and (A-I)rHDL to inhibit ROS generation, decrease expression of the catalytic subunit of NADPH oxidase (Nox2), and increase expression of the cytosolic and mitochondrial SOD1 and SOD2 was also investigated (Figure 3 ). After 8 hours of incubation with 25 mmol/L glucose, Nox2 mRNA levels increased by 55Ϯ21% (PϽ0.05), but SOD1 or SOD2 mRNA levels were not affected ( Figure 3A) . Preincubation of HMDM with lipid-free apoA-I or (A-I)rHDL attenuated the 25 mmol/L glucose-induced increase in Nox2 mRNA expression by 53Ϯ24% (PϽ0.01) and 56Ϯ10% (PϽ0.05), respectively. Preincubation with lipid-free apoA-I and (A-I)rHDL increased SOD1 mRNA levels by 136Ϯ43% (PϽ0.05) and 70Ϯ16% (PϽ0.05), respectively, and SOD2 mRNA levels by 275Ϯ37% (PϽ0.05) and 273Ϯ87% (PϽ0.05).
Similar changes in Nox2, SOD1, and SOD2 protein expression were observed when HMDM that had been preincubated with lipid-free apoA-I and (A-I)rHDL were incubated for 8 hours with 25 mmol/L glucose ( Figure 3B ). These incubations had no effects on cell viability as assessed by Evans blue staining (not shown).
Regulation of Nox2, SOD1, and SOD2 by ABCA1, SR-BI, and ABCG1
We used RNA interference to determine whether ABCA1, SR-BI, or ABCG1 knockdown affects the ability of lipid-free apoA-I and (A-I)rHDL to modulate glucose-induced changes in Nox2, SOD1, and SOD2 protein expression in HMDM. Transfection of cells with Alexa Fluor 488 -labeled siRNA for ABCA1, SR-BI, and ABCG1 induced an increase in cell fluorescence 6 hours posttransfection, indicating that the siRNA had been incorporated into the cells (Supplemental Figure IVA) . At 24, 48, or 72 hours following transfection, the cells were harvested, and protein expression was assessed by Western blot analysis. Compared with scrambled siRNA, ABCA1 protein expression was decreased by 56Ϯ7% (PϽ0.01) at 24 hours posttransfection (Supplemental Figure  IVB) . SR-BI (Supplemental Figure IVC) and ABCG1 (Supplemental Figure IVD) protein expression was decreased by 77Ϯ6% and 54Ϯ5% (PϽ0.01 for both), respectively, at 72 hours posttransfection. These time points were used for the subsequent experiments.
In control HMDM transfected with scrambled siRNA (Figure 4A ), apoA-I and (A-I)rHDL inhibited the highglucose-induced expression of Nox2 protein to the same extent as in nontransfected cells (see Figure 3B) . In HMDM transfected with ABCA1 siRNA, the ability of lipid-free apoA-I (but not discoidal [A-I]rHDL) to inhibit 25 mmol/L glucose-induced Nox2 expression was decreased but did not reach significance ( Figure 4B ). In cells transfected with SR-BI and ABCG1, the effect of apoA-I on 25 mmol/L glucose-induced increase in Nox2 protein expression was comparable to that observed in HMDM transfected with scrambled siRNA (Figure 4C and 4D) . The ability of discoidal (A-I)rHDL to inhibit 25 mmol/L glucose-induced increase in Nox2 protein expression was lost only in the cells transfected with ABCG1 siRNA ( Figure 4D ).
We next examined whether silencing ABCA1, SR-BI, or ABCG1 influenced lipid-free apoA-I and (A-I)rHDL-induced increase in SOD1 protein expression in the presence of 25 mmol/L glucose ( Figure 5 ). In HMDM transfected with scrambled siRNA, preincubation with lipid-free apoA-I and (A-I)rHDL increased SOD1 protein expression by 53Ϯ15% (PϽ0.01) and 66Ϯ26% (PϽ0.05), respectively ( Figure 5A ). The ability of lipid-free apoA-I to influence SOD1 protein expression was lost in HMDM in which ABCA1 was silenced ( Figure 5B ), whereas the ability of (A-I)rHDL to influence SOD1 expression was lost in HMDM transfected with SR-BI siRNA ( Figure 5C ) and ABCG1 siRNA ( Figure 5D) .
Similarly, SOD2 levels were increased (PϽ0.05) by lipidfree apoA-I in HMDM transfected with scrambled siRNA ( Figure 6A ) but not in cells in which ABCA1 was silenced ( Figure 6B ). The ability of (A-I)rHDL to increase SOD2 protein levels was inhibited in HMDM transfected with SR-BI siRNA ( Figure 6C ) and ABCG1 siRNA ( Figure 6D ) compared with cells transfected with a scrambled siRNA ( Figure 6A ).
Inhibition of ROS Production in HMDM by Lipid-Free apoA-I From Subjects With Diabetes
HMDM were preincubated for 16 hours with either lipid-free apoA-I from normolipidemic subjects (nϭ5) or apoA-I from subjects with T2D (nϭ5) and then incubated for a further 8 hours with 25 mmol/L glucose. Intracellular ROS production was measured using DHE fluorescence (Supplemental Figure  V) . Incubation of HMDM with 25 mmol/L glucose increased ROS production by 33Ϯ5% (PϽ0.05). Preincubation with lipid-free apoA-I from subjects with T2D inhibited ROS production less effectively than the lipid-free apoA-I from normal subjects (18Ϯ3% versus 39Ϯ3%, PϽ0.01).
Discussion
In this study, we showed that under high-glucose conditions, macrophage ROS generation was inhibited by apoA-I, the main apolipoprotein of HDL, regardless of whether the apolipoprotein was in a lipid-free form or a constituent of reconstituted discoidal (A-I)rHDL. We found, moreover, that native HDL inhibited ROS generation in HMDM incubated with high glucose, thus suggesting that HDL and its apolipo- proteins may modulate redox status in human macrophages under hyperglycemic conditions. This was also consistent with apoA-I isolated from subjects with T2D having impaired antioxidant properties.
The ability of HDL and their lipid and apolipoprotein constituents to decrease agonist-induced ROS generation has been reported previously. 21, 30 However, not all studies have shown that lipid-free apoA-I decreases ROS production; indeed, Tölle et al have reported that the HDL-associated lysophospholipids sphingosine-1-phosphate and sphingosylphosphorylcholine, but not apoA-I, inhibited ROS production in vascular smooth muscle cells following stimulation with thrombin. 31 The reason for these differences is uncertain but may relate to the various cell types and agonists that were used.
In human macrophages, ROS originate from membrane and mitochondrial enzymatic resources. 32 The catalytic core of NADPH oxidase includes an enzyme complex composed of Nox2 (also known as gp91phox) and p22phox. Nox2 is directly involved in superoxide production, as it contains the complete electron-transferring apparatus from NADPH to molecular oxygen. 33 Results from this study suggested that the antioxidant properties of HDL under hyperglycemic conditions include the inhibition of NADPH oxidasedependent ROS generation on one hand and the upregulation of antioxidant enzymes on the other. Activation of both of these pathways has been shown to play an important role in the acceleration of atherosclerosis in T2D. 34 A previous study has indicated that exposure of vascular smooth muscle cells to a highly specific cell-permeable inhibitor of NADPH oxidase (gp91ds) preempted the inhibition of NADPH consumption and superoxide generation by HDL. 31 Collectively, these results indicate that NADPH oxidase is a target enzyme for HDL.
Members of the ATP binding cassette transporter family (ABCA1 and ABCG1) and SR-BI are known regulators of cellular lipid metabolism. 35, 36 Their function in removing cellular cholesterol from macrophages is well established. 37 In line with a previous study from our laboratory, 38 we showed that the antioxidant properties of lipid-free apoA-I were dependent on ABCA1, whereas the (A-I)rHDLmediated antioxidant effects were dependent on ABCG1 and SR-BI. Given that lipid-free apoA-I accepts the cholesterol that is exported from cells via ABCA1, 39 these results suggest that the antioxidant effects of lipid-free apoA-I were linked to cellular cholesterol efflux and thus to their ability to interact with the cell membrane transporter. Indeed, it is now well documented that lipid-free apoA-I has the ability to interact with ABCA1, but not ABCG1, and that discoidal (A-I)rHDL interacts with ABCG1 and SR-BI. [35] [36] [37] 39 Previous studies have shown that SR-BI is linked to systemic and tissue oxidative stress in animal models. 40 Similarly, ABCG1 expression has also been shown to be associated with diabetes. 41 In db/db diabetic mice, ABCG1 downregulation is associated with impaired cholesterol efflux to HDL and increased macrophage esterified cholesterol content. 42 Here, we showed that under hyperglycemic conditions, SR-BI and ABCG1 knockdown reduced the ability of discoidal (A-I)rHDL to increase SOD1 and SOD2 in HMDM. Given that discoidal (A-I)rHDL acts as an acceptor of cholesterol that effluxes from cells via ABCG1 and SR-BI 42,43 our study, together with others, 40 suggests that (A-I)rHDL may trigger downstream signaling pathways via SR-BI and ABCG1 that are linked to cholesterol efflux and that the selective disruption of these transporters and the receptor may have an impact on oxidative stress damage in hyperglycemic conditions. Recent work from our laboratory has shown that glycation alters the conformation of apoA-I in regions that are critical for activation of lecithin: cholesterol acyltransferase, a key enzyme in the reverse cholesterol transport pathway. 24 Furthermore, in another study, we showed that in human endothelial cells and rabbit carotid arteries, the nonenzymatic glycation of apoA-I, either by incubation with methylglyoxal or as a consequence of the persistent hyperglycemia of diabetes, attenuates the antiinflammatory and antioxidant properties of HDL by reducing the ability of apoA-I to inhibit nuclear factor-B activation and ROS formation. 25 Here, we demonstrate that apoA-I isolated from subjects with diabetes is less able to inhibit macrophage ROS generation than is the apoA-I isolated from healthy subjects. It is possible, therefore, that the altered antioxidant properties of apoA-I from subjects with T2D may be a consequence of nonenzymatic glycation of apoA-I. 22,44 -46 Along with our findings, a previous study showed that in rat hepatoma cells, the ability of the serum from subject with T2D to induce cholesterol efflux was impaired. 47 In conclusion, we have shown that HDL and their major apolipoprotein, apoA-I, inhibit hyperglycemia-induced oxidative stress and NADPH-mediated ROS production in human macrophages. Interestingly, apoA-I antioxidant properties were mediated via ABCA1, whereas the (A-I)rHDL effects were associated with ABCG1 and SR-BI signaling pathways. Finally, we showed that T2D reduced the antioxidant properties of human apoA-I.
